Drug General Information
Drug ID	D0T9PL
Former ID	DIB011072
Drug Name	BLV-0703
Synonyms	BLV-200703; KTP-NH2; TAU-targeting compound (CNS disorders), Bioalvo
Indication	Central nervous system disease [ICD10:G00-G99]		Investigative	[531616]
Company	Bioalvo SA
Structure		Download 2D MOL 3D MOL
Canonical SMILES	N([C@H](C(=O)N)CCCNC(=N)N)C(=O)[C@@H](N)Cc1ccc(cc1)O
Target and Pathway
Target(s)	Microtubule-associated protein tau	Target Info	Modulator	[531616]
KEGG Pathway	MAPK signaling pathway
	Alzheimer's disease
NetPath Pathway	IL2 Signaling Pathway
	EGFR1 Signaling Pathway
Pathway Interaction Database	LPA receptor mediated events
	Reelin signaling pathway
Reactome	Caspase-mediated cleavage of cytoskeletal proteins
WikiPathways	Notch Signaling Pathway
	IL-2 Signaling Pathway
	MAPK Signaling Pathway
	Copper homeostasis
	Kit receptor signaling pathway
	BDNF signaling pathway
	Integrated Pancreatic Cancer Pathway
	Alzheimers Disease
	Regulation of Microtubule Cytoskeleton
	Apoptotic execution phase
	IL-5 Signaling Pathway
References
Ref 531616	Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). Curr Pharm Des. 2011;17(31):3413-7.
Ref 531616	Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). Curr Pharm Des. 2011;17(31):3413-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.